COEP
NASDAQ · Biotechnology
Coeptis Therapeutics Holding
$3.36
+0.01 (+0.30%)
Open$3.34
Previous Close$3.35
Day High$3.50
Day Low$3.17
52W High$21.41
52W Low$2.11
Volume—
Avg Volume323.4K
Market Cap102.06M
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 8.74M | 7.84M |
| Net Income | -17,995,573 | -2,031,310 | -1,359,886 |
| Profit Margin | -874.3% | -23.2% | -17.3% |
| EBITDA | -18,585,812 | -2,389,064 | -2,398,436 |
| Free Cash Flow | — | -1,186,852 | -1,098,506 |
| Rev Growth | — | +14.6% | -0.2% |
| Debt/Equity | 0.02 | 0.28 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |